| Copper | Approved Investigational | ARMCX5 | 64860 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ARMCX5 mRNA | Xq22.1 | |
| Copper | Approved Investigational | ARNTL | 406 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ARNTL mRNA | 11p15.3 | |
| Copper | Approved Investigational | ARRB1 | 408 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ARRB1 mRNA | 11q13.4 | |
| Copper | Approved Investigational | ARRDC4 | 91947 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ARRDC4 mRNA | 15q26.2 | |
| Copper | Approved Investigational | ARSD | 414 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ARSD mRNA | Xp22.33 | |
| Copper | Approved Investigational | ASB13 | 79754 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ASB13 mRNA | 10p15.1 | |
| Copper | Approved Investigational | ASB9 | 140462 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ASB9 mRNA | Xp22.2 | |
| Copper | Approved Investigational | ASF1B | 55723 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ASF1B mRNA | 19p13.12 | |
| Copper | Approved Investigational | ASGR1 | 432 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of ASGR1 mRNA | 17p13.1 | |
| Copper | Approved Investigational | ASIC1 | 41 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ASIC1 mRNA | 12q13.12 | |
| Copper | Approved Investigational | ASMTL | 8623 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of ASMTL mRNA | Xp22.3 and Yp11.3 | |
| Copper | Approved Investigational | ASNS | 440 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of ASNS mRNA | 7q21.3 | |
| Copper | Approved Investigational | ASNS | 440 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ASNS mRNA | 7q21.3 | |
| Copper | Approved Investigational | ASPH | 444 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ASPH mRNA | 8q12.3 | |
| Copper | Approved Investigational | ASRGL1 | 80150 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ASRGL1 mRNA | 11q12.3 | |
| Copper | Approved Investigational | ASTN2 | 23245 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ASTN2 mRNA | 9q33.1 | |
| Copper | Approved Investigational | ATAD2 | 29028 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ATAD2 mRNA | 8q24.13 | |
| Copper | Approved Investigational | ATAD3A | 55210 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ATAD3A mRNA | 1p36.33 | |
| Copper | Approved Investigational | ATF3 | 467 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of ATF3 mRNA | 1q32.3 | |
| Copper | Approved Investigational | ATF3 | 467 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ATF3 mRNA | 1q32.3 | |
| Copper | Approved Investigational | ATG101 | 60673 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of ATG101 mRNA | 12q13.13 | |
| Copper | Approved Investigational | ATP2B4 | 493 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ATP2B4 mRNA | 1q32.1 | |
| Copper | Approved Investigational | ATP5G3 | 518 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ATP5G3 mRNA | 2q31.1 | |
| Copper | Approved Investigational | ATP5S | 27109 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ATP5S mRNA | 14q21.3 | |
| Copper | Approved Investigational | ATP6AP1L | 92270 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ATP6AP1L mRNA | 5q14.2 | |